HOME >> BIOLOGY >> NEWS
Studies offer data on potential impact of Reminyl on caregiver 'burden' in Alzheimer's disease

ily living, such as dressing and bathing.

Included in the analysis were 435 patients with mild to moderate Alzheimer's disease who had been randomly assigned to receive either 24 mg of Reminyl daily (220) or placebo (215) for six months as part of a larger study conducted in Europe and Canada. The primary efficacy measures used in the study were tools to assess patients' ability to learn, think and reason (the cognitive portion of the Alzheimer's Disease Assessment Scale) and the treating physician's overall impression of patients' function, along with input from caregivers (Clinicians Interview-Based Impression of Change plus Caregiver Information). However, as one of the secondary measures, the primary caregivers in the patients' families were asked to complete a questionnaire on the time they spent on supervision and assistance. The analysis found that the time required to supervise patients who received placebo increased by approximately two hours per day over the six months. In contrast, the time spent supervising individuals who took Reminyl did not increase significantly. In addition, the time that caregivers spent assisting patients on placebo with daily-living activities increased steadily throughout the trial, totalling an average of 23 extra minutes per day by the end of six months. On the other hand, caregivers of patients taking Reminyl reported a decrease in the amount of time spent assisting their charges by an average of 38 minutes per day.

"A reduction in time required for assistance isn't just a convenience and relief for the caregiver, it's also a reflection of increased independence for the person with Alzheimer's, which makes it a 'win-win' situation," comments Prof. Wilcock. The longer we can preserve independent functioning for the patient, the more dignity and quality social interaction is possible."

Reducing Caregiver Stress

A separate analysis of a different study focused on caregiver distress and was cond
'"/>

Contact: Andrew Cooper
andrew.cooper@ketchum.com
44-020-7611-3859
Ketchum
13-Sep-2001


Page: 1 2 3 4

Related biology news :

1. Monkey business: Studies show tiny callimicos have unusual characteristics
2. Studies show success of Mectizan partnerships
3. Studies offer new insight into HIV vaccine development
4. Studies suggest brain injury results from developmental exposure to alcohol, anesthesia, and lead
5. Studies show preventive value of food supplements
6. Studies probe rapid evolution of Chinese tallow trees
7. Studies of rare blood syndrome yield novel route to cancer
8. Studies dispute ultraviolet effect on amphibian population declines
9. Studies of spiders silk reveal unusual strength
10. Studies of genes in mice and common worm may accelerate research on blood diseases, cancers
11. Studies: Floyd, other major hurricanes of 99 caused significant changes in nations largest lagoonal estuary

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... ... August 03, 2020 , ... Accumen ... partnership with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits ... laboratory supply chain for more than 10 years. Early in the COVID-19 crisis, ...
(Date:7/18/2020)... ... , ... Commercial launch readiness is a critical stage in a product life ... vaccine, the global economic downturn will only increase price pressures overall for the industry. ... full value from every product launch is critical. However, history shows that only a ...
(Date:7/2/2020)... FREDERICK, Md. (PRWEB) , ... ... ... company, Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the ... a one-step reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 30, ... ... of cloud-based software for the life sciences industry, today announced the release ... platform designed specifically for Medical Science Liaisons (MSLs) and other field medical ...
(Date:7/18/2020)... ... 2020 , ... Medial EarlySign , a leader in ... high-burden diseases, and Centric Consulting, a business and technology consulting firm, today announced ... in order to identify and prioritize patients for care. , Combining Centric’s management ...
(Date:7/10/2020)... ... July 09, 2020 , ... In ... commonly used to suppress pigment formation in zebrafish embryos, maintaining optical transparency to ... by Dr MA has been using the zebrafish model to investigate the causes ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a ... 2020, despite many obstacles created as a result of COVID-19. As a provider ... partnered medical practices and medical manufacturers by expanding access to device offerings, technology ...
Breaking Biology Technology:
Cached News: